Výsledky vyhledávání - "Matthew A.T. Croco"

Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)

Autor: Matthew A.T. Croco, Mondell L. Beach, Ronald N. Jones, Michael A. Pfaller, Kari C. Kugler

Publikováno v: Diagnostic Microbiology and Infectious Disease. 37:115-125

Thirty-seven sentinel hospitals (29 in the United States [US]; eight in Canada) collected bacterial isolates from hospitalized patients with a diagnosis of pneumonia. The antimicrobial susceptibility patterns of these pathogens were determined to mor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8136f6a3b29fcaf2146b1a5c1a72c208
https://doi.org/10.1016/s0732-8893(00)00115-2

Zobrazit plný text záznamu

Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, moraxella catarrhalis, and streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results

Autor: Matthew A.T. Croco, M.Todd Lewis, Douglas J. Biedenbach, Ronald N. Jones, Mary S. Barrett

Publikováno v: Diagnostic Microbiology and Infectious Disease. 33:275-282

The use of macrolides for treatment of respiratory complaints has been complicated by susceptibility test conditions that adversely effect the in vitro test results and perceived potencies of these compounds. Dirithromycin was studied as to its in vi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2f09072cd3cec44ac4b4401a99409482
https://doi.org/10.1016/s0732-8893(98)00157-6

Zobrazit plný text záznamu

BAY 12-8039, a novel fluoroquinolone

Autor: Douglas J. Biedenbach, Matthew A.T. Croco, Mary S. Barrett, Ronald N. Jones

Publikováno v: Diagnostic Microbiology and Infectious Disease. 32:45-50

BAY 12-8039 or moxifloxacin is a new 8-methoxyquinolone with documented, improved activity against Gram-positive cocci and anaerobic bacteria. This study tested 1250 commonly isolated respiratory tract pathogens (251 Moraxella catarrhalis, 499 Haemop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::82811b7f2ee059349f579649c48c37b2
https://doi.org/10.1016/s0732-8893(98)00042-x

Zobrazit plný text záznamu

In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae

Autor: Matthew A.T. Croco, Ronald N. Jones, Mary S. Barrett, Douglas J. Biedenbach

Publikováno v: Diagnostic Microbiology and Infectious Disease. 31:573-578

Cefditoren (formerly ME-1206), a new orally administered cephalosporin, was evaluated in vitro against 1249 recently isolated strains of Streptococcus pneumoniae (500 strains), Moraxella catarrhalis (250 strains), and Haemophilus influenzae (499 stra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134bdce077b8dd1155a190a766ffbae4
https://doi.org/10.1016/s0732-8893(98)00044-3

Zobrazit plný text záznamu

Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997)

Autor: Ronald N. Jones, Matthew A.T. Croco, Kari C. Kugler, Mondell L. Beach, Michael A. Pfaller

Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 5(9)

OBJECTIVE: To investigate the in vitro potency and spectrum of activity of gatifloxacin and five comparator fluoroquinolones tested against over 23 000 clinical isolates from diverse geographic and clinical sources in the Americas. METHODS: Gram-nega

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99cb631bb84677dfaa4486779c39a76
https://pubmed.ncbi.nlm.nih.gov/11851706

Zobrazit plný text záznamu

Antimicrobial Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia spp

Autor: David M. Johnson, R N Jones, Matthew A.T. Croco, Steven A. Marshall, Douglas J. Biedenbach

Publikováno v: Drugs. 58:180-181

Stenotrophomonas maltophilia and Burkholderia spp. are ubiquitous organisms that often establish themselves within the hospital environment and can cause devastating nosocomial infections in patients suffering from cystic fibrosis and others with com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::51276bb2a2a8c27c34e54389cc97d415
https://doi.org/10.2165/00003495-199958002-00052

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání